| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |